Partial agonistic activity of labetalol, the arylethanolamine, on β3-adrenoceptors in the guinea-pig gastric fundus

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 1, 2002, Pages 29-35

  Horinouchi, T ^a   Asai, S ^a   Fukushima, M ^a   Koike, K ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID METHYL ESTER; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; BUTOXAMINE; ISOPRENALINE; LABETALOL; NORADRENALIN; PARTIAL AGONIST; ETHANOLAMINE;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG STRUCTURE; GUINEA PIG; NONHUMAN; STOMACH FUNDUS; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG POTENTIATION; IN VITRO STUDY; MALE; MUSCLE RELAXATION; PHYSIOLOGY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINE; GASTRIC FUNDUS; GUINEA PIGS; LABETALOL; MALE; MUSCLE RELAXATION; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0036479440     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00239.x     Document Type: Article

References (27)

1. AINSWORTH, A.T. & SMITH, D.G. (1980). Ethanamine derivatives: their preparation and use in pharmacological compositions. European Patent, 02385.
2. 3- and atypical β-adrenoceptors. Med. Res. Rev., 13, 663-729.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
4. BIANCHETTI, A. & MANARA, L. (1990). In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical β-adrenoceptors in rat colon. Br. J. Pharmacol., 100, 831-839.
5. BRITTAIN, R.T., DREW, G.M. & LEVY, G.P. (1982). The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. Br. J. Pharmacol., 77, 105-114.
6. BRITTAIN, R.T. & LEVY, G.P. (1976). A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br. J. Clin. Pharmacol., 3, 681-684.
7. CAREY, B. & WHALLEY, E.T. (1979a). β-Adrenoceptor agonist activity of labetolol on the isolated uterus of the rat. Br. J. Pharmacol., 67, 13-15.
8. CAREY, B. & WHALLEY, E.T. (1979b). Labetalol possesses β-adrenoceptor agonist action on the rat isolated uterus. J. Pharm. Pharmacol., 31, 791-792.
9. CARPENTER, J.R. (1981). Intrinsic activity of labetalol on guinea-pig isolated trachea. J. Pharm. Pharmacol., 33, 806-807.
10. COLEMAN, R.A., DENYER, L.H. & SHELDRICK, K.E. (1987). β-Adrenoceptors in guinea-pig gastric fundus - are they the same as the 'atypical' β-adrenoceptors in rat adipocytes? Br. J. Pharmacol., 90, 40P.
11. FARMER, J.B., KENNEDY, I., LEVY, G.P. & MARSHALL, R.J. (1972). Pharmacology of AH 5158; a drug which blocks both α- and β-adrenoceptors. Br. J. Pharmacol., 45, 660-675.
12. 3-adrenoceptor antagonist bupranolol. Pharmacology, 59, 290-297.
13. HORINOUCHI, T. & KOIKE, K. (1999b). Characterization of atypical β-adrenoceptors in the guinea-pig duodenum. Eur. J. Pharmacol., 376, 61-66.
14. HORINOUCHI, T. & KOIKE, K. (2000a). Partial agonist activity of carteolol on atypical β-adrenoceptors in the guinea-pig duodenum. Eur. J. Pharmacol., 403, 133-138.
15. HORINOUCHI, T. & KOIKE, K. (2000b). Partial agonistic effects of carteolol on atypical β-adrenoceptors in the guinea-pig gastric fundus. Jpn. J. Pharmacol., 84, 287-292.
16. HORINOUCHI, T. & KOIKE, K. (2001a). Functional properties of atypical β-adrenoceptors on the guinea-pig duodenum. Eur. J. Pharmacol., 416, 153-163.
17. HORINOUCHI, T. & KOIKE, K. (2001b). (±)-Pindolol acts as a partial agonist at atypical β-adrenoceptors in the guinea-pig duodenum. Jpn. J. Pharmacol., 85, 35-40.
18. KAUMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 93-98.
19. 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
20. KOIKE, K., HORINOUCHI, T. & TAKAYANAGI, I. (1995). Possible mechanisms of β-adrenoceptor-mediated relaxation induced by noradrenaline in guinea-pig taenia caecum. Eur. J. Pharmacol., 279, 159-163.
21. 3-adrenoceptors in pithed rat. Br. J. Pharmacol., 122, 1307-1314.
22. 3-Adrenoceptors and intestinal motility. Fund. Clin. Pharmacol., 9, 332-342.
23. ORIOWO, M.A., CHAPMAN, H., KIRKHAM, D.M. SENNITT, M.V., RUFFOLO, R.R. JR & CAWTHORNE, M.A. (1996). The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344. J. Pharmacol. Exp. Ther., 277, 22-27.
24. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci., 25, 637-654.
25. VAN ROSSUM, J.M. (1963). Cumulative dose-response curves, II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn., 143, 299-330.
26. WHALLEY, E.T. (1977). The cardiovascular and uterine effects of labetolol in conscious normotensive pregnant rats. Br. J. Pharmacol., 61, 505P-506P.
27. WHALLEY, E.T. (1980). Observations on the effect of labetalol on pregnancy and parturition in normotensive rats. Gen. Pharmacol., 11, 297-302.